PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The objective of this study is to assess the efficacy of weekly PG2 regimen as a complementary treatment for patients with recurrent unresectable (local or regional) or metastatic breast cancer who experienced moderate to severe fatigue while receiving chemotherapies.
Epistemonikos ID: 311cff74e885a3837046406160884adb512d3262
First added on: May 13, 2024